stocks rarely recover from the grey market. i was trying to

New Post Public Reply Private Reply Replies (0) Message Board
joey68
618
stocks rarely recover from the grey market. i was trying to say this for years and years here. pick up the pieces, dont give up investing, find the next investment and go there. im telling you, most investors never make a dime simply because they dont know when to quit.

Baltia Air Lines Inc (BLTA) Stock Research Links

BLTA Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SPECS Framework: Rethinking Career Growth Strategies

Updated Category News Views 61

An Evolving Workplace Demands Evolving Strategies Look, careers ain't what they used to be—and they shouldn't be. Today’s world is flipping the script on how we work, and Dr. Brandi R. Muñoz is rewriting the book on career development with her SPECS framework. The guy clinging to his outdated Rolodex for advice isn't gonna cut it anymore. "Who Are Your SPECS?...

Continue Reading
Bird-X Welcomes Doolittle to Elevate Sales Strategy

Updated Category News Views 105

Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...

Continue Reading
Goodal Skincare Capitalizes on K-Beauty Craze at Costco

Updated Category News Views 38

A Venture into American Retail Goodal, the darling of Korea's skincare scene, is staking its claim at Costco. This is no small feat, my friends. We're talkin' about a brand that's carved out a sweet niche with its Green Tangerine line. Now it's hitching its wagon to one of America's retail behemoths, known for its unique knack in beauty products. From Olive Young to...

Continue Reading
DUPR Teams Up with InBody to Elevate Pickleball Fitness

Updated Category News Views 0

Well, here's a twist in the pickleball world—DUPR and InBody have struck a deal to bring top-notch body composition tech to the ever-expanding universe of pickleballers. They're merging power players from two different worlds to tap into your performance on the court and your wellness off it. Maybe I'm just jaded from too many marketing pitches, but this one could...

Continue Reading
PG&E's $2B Delay: A Blame Game or Real Crisis?

Updated Category News Views 163

Just when you think the circus of energy utilities couldn't get any more outlandish, PG&E grabs the spotlight once more. Picture this: they've got the megaphone out, threatening to put the brakes on $2 billion in crucial infrastructure investments. Twenty-five thousand customers left hanging, just waiting for their lights to come on. As if that's not enough, PG&E is also...

Continue Reading
Telemed Sites Need Solid Payment Systems with AI

Updated Category News Views 54

Brace for Impact: Payment Processors in Telehealth A new era is brewing in telehealth, with AI coding tools making website creation a breeze for healthcare folks. But here's the kicker: accepting credit cards is not as easy as setting up a snazzy booking page. Take it from Organic Payment Gateways in good ol' Scarborough, Maine, who've decided to toss their hat into this...

Continue Reading
Luxury Vinyl Tiles Market Set for Steady Growth to 2031

Updated Category News Views 69

Luxury Vinyl Tiles: A Market on the Rise Well, folks, the flooring game is picking up steam, and luxury vinyl tiles (LVT) are in the spotlight. With consumers and businesses all looking for something durable yet easy on the eyes and wallet, LVT is answering the call. MarketsandMarkets™ reports that this sector is expected to balloon from USD 18.22 billion in 2026 to USD...

Continue Reading
Bright Minds in Hot Water: Investigation Shakes Investors

Updated Category News Views 91

FDA Throws Wrench Into Bright Minds' Plans This ain't the first time a biotech company's dream has hit the skids, but Bright Minds Biosciences (NASDAQ:DRUG) found themselves in the meat grinder when the FDA threw their epilepsy trial plans under the bus. The partial clinical hold wasn't a gentle slap on the wrist, but a gut punch driven by mouse toxicity findings and...

Continue Reading
ESAC Redefines Entertainment Centers, Eyes 2027 Trends

Updated Category News Views 107

A New Era for Family Entertainment Centers Forget the traditional FEC with its solitary rides; the future's all about constructing social destinations that blend immersive storytelling and hybrid offerings. Elephant Sculpture Art Co., Ltd. (ESAC) is at the forefront, drawing from their Shanghai WUNPARK project to reimagine the design of these amusement hubs. Set to engage...

Continue Reading
AMETEK Surpasses Q3 2026 Expectations, Raises Outlook

Updated Category News Views 11

A Banner Quarter for AMETEK Holy smokes, AMETEK has thrown down some numbers for the third quarter of 2026 that would make any seasoned trader sit up and take notice. We’re talking record-breaking across the board: $2.22 billion in sales, marking a whopping 17% increase over last year. Now, that's not just growth—that's rocket fuel. Earnings per share rocketed up with...

Continue Reading

Top 5 Most Recently Viewed Articles

ThredUp Reports Q3 2024 Financial Results; Outlook Brightens

Updated Category News Views 55

ThredUp Financial Results for the Third Quarter In the recently concluded third quarter, ThredUp Inc. (NASDAQ: TDUP) reported total revenue of $73 million, marking an 11% decline year-over-year. This decline stems from various market factors influencing the resale industry. Revenue Breakdown and Margins The U.S. market alone contributed $61.5 million to the overall...

Continue Reading
Tesla Faces Sales Challenges in Europe Amidst Controversies

Updated Category News Views 372

Tesla's Declining Sales in Key European Markets Tesla Inc (NASDAQ: TSLA) is facing significant sales declines in several European countries as reported in early 2025. These drops, drastic in some cases, seem to be a reflection of growing consumer dissatisfaction linked to CEO Elon Musk's heightened political involvement. The Impact of Elon Musk's Political Engagement As...

Continue Reading
Dermata Therapeutics Faces Market Challenges with Stock at $1.28

Updated Category News Views 48

Dermata Therapeutics and its Recent Stock Performance In a highly competitive market landscape, Dermata Therapeutics Inc. (DRMA) has experienced a significant decline in stock value, recently hitting a 52-week low of $1.28. As a biotechnology company specializing in dermatological treatments, Dermata has encountered considerable challenges over the past year, resulting in...

Continue Reading
Indonesia Advances in Critical Minerals for EV & Green Technologies

Updated Category News Views 138

Indonesia's Commitment to the Critical Minerals Industry Fastmarkets proudly reveals an important partnership with the Ministry of Investment and Downstream Industry of Indonesia. This collaboration highlights Indonesia's strategy to boost its role in the global supply chain of critical minerals, aiming to support a sustainable economy centered around clean energy...

Continue Reading
Cox Automotive Revolutionizes Vehicle Appraisal with AI

Updated Category News Views 270

Cox Automotive's Innovative Integration with UVeye Cox Automotive is at the forefront of automotive technology, consistently advancing how dealerships operate. In a recent development, they have integrated their distinctive vAuto platform with UVeye. This integration marks a significant milestone in improving vehicle appraisal processes, allowing for greater efficiency...

Continue Reading